Prestige Consumer Healthcare Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 251.51 M

Prestige Consumer Healthcare Inc. Operating Cash Flow is USD 251.51 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 1.04% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Prestige Consumer Healthcare Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 248.93 M, a 8.36% change year over year.
  • Prestige Consumer Healthcare Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 229.72 M, a -11.62% change year over year.
  • Prestige Consumer Healthcare Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 259.92 M, a 10.32% change year over year.
  • Prestige Consumer Healthcare Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 235.61 M, a 8.51% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities